Thursday, October 22, 2026
25.6 C
Bengaluru

Indian Pharma Market Through a Game Theory Lens

A Salil Kallianpur Blog

  • Explosive value growth, limited volume growth – IPM expanded massively in value since the 1990s, driven by higher prices, premium therapies, and chronic disease management, but didn’t proportionally expand in terms of medicine volumes sold.
  • Population & income growth concentrated demand – Even though India’s population doubled and the middle class surged, demand stayed concentrated in urban areas because healthcare is a superior good (spending rises faster with income).

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...
spot_img

Related Articles

spot_imgspot_img